David J Mazzo is President & CEO of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 311,890 shares of CLBS, which is worth approximately $1.1 Million. The most recent transaction as insider was on Jan 13, 2021, when has been sold 39,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 312K
17.83% 3M change
17.83% 12M change
Total Value Held $1.1 Million

David J Mazzo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 13 2021
BUY
Grant, award, or other acquisition
-
39,000 Added 10.47%
333,653 Common Stock
Jan 11 2021
SELL
Payment of exercise price or tax liability
$26,427 $1.59 p/Share
16,621 Reduced 5.34%
294,653 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
119,000 Added 27.66%
311,274 Common Stock
Jan 08 2021
SELL
Payment of exercise price or tax liability
$7,562 $1.6 p/Share
4,726 Reduced 2.4%
192,274 Common Stock

Also insider at

PALI
PALISADE BIO, INC. Healthcare
DJM

David J Mazzo

President & CEO
Basking Ridge, NJ

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Track Activities on CLBS